MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Conditions
- Leiomyosarcoma
- Liposarcoma
- Synovial Sarcoma
- Angiosarcoma
- Undifferentiated Pleomorphic Sarcoma
- Epithelioid Sarcoma
- Malignant Peripheral Nerve Sheath Tumors
- Fibrosarcoma
- Pleomorphic Rhabdomyosarcoma
- Endometrial Stromal Sarcoma
- Desmoplastic Small Round Cell Tumor
Interventions
- BIOLOGICAL: MASCT-I
- DRUG: Doxorubicin
- DRUG: Ifosfamide
Sponsor
HRYZ Biotech Co.
Collaborators